american-health-council-logo-210x126.jpg
The American Health Council Physician Board Welcomes Marvin Faulkner, DO, BA
June 11, 2018 08:00 ET | American Health Council
NEW YORK, June 11, 2018 (GLOBE NEWSWIRE) -- The American Health Council welcomes Marvin Faulkner, DO, BA to its Board of Physicians for his outstanding contributions to the medical field.  As a pain...
american-health-council-logo-210x126.jpg
John Baker, MD is Honored by the American Health Council for “Best in Medicine”
January 15, 2018 11:15 ET | American Health Council
NEW YORK, Jan. 15, 2018 (GLOBE NEWSWIRE) -- The American Health Council is honored to name John Baker, MD as one of America’s “Best in Medicine.” Owner and head surgeon of Allegiance Orthopedic and...
american-health-council-logo-210x126.jpg
Dr. Keith A. Perry Named to the American Health Council’s Physician Board
September 29, 2017 11:51 ET | American Health Council
NEW YORK, Sept. 29, 2017 (GLOBE NEWSWIRE) -- Dr. Keith A. Perry, Medical Director of Precision Pain Treatment Clinic in Smithfield, Rhode Island, has been elected to join the American Health...
american-health-council-logo-210x126.jpg
American Health Council Honors Joseph Pergolizzi, Jr., MD as Best in Medicine
August 22, 2017 10:19 ET | American Health Council
NEW YORK, Aug. 22, 2017 (GLOBE NEWSWIRE) -- The American Health Council is proud to elect Dr. Joseph Pergolizzi, Jr. as one of “America’s Best Doctors”, recognizing his expertise in Clinical...
TrevenaLogo.jpg
Trevena Announces Presentations at the 42nd Annual Regional Anesthesiology and Acute Pain Medicine Meeting
April 06, 2017 07:00 ET | Trevena Inc.
KING OF PRUSSIA, Pa., April 06, 2017 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced the first scientific presentation of positive results from two Phase 3 pivotal efficacy studies...
TrevenaLogo.jpg
Trevena Announces Positive Top-line Results from Two Phase 3 Pivotal Efficacy Studies of Intravenous Oliceridine in Moderate-to-Severe Acute Pain
February 21, 2017 07:00 ET | Trevena Inc.
–  Program is on track for NDA submission in 4Q 2017  – –  OLINVOTM to be the proprietary brand name for oliceridine  ––  Company to host conference call and webcast at 8:00...
TrevenaLogo.jpg
Trevena Completes Enrollment of Phase 3 APOLLO Pivotal Efficacy Trials of Oliceridine for Moderate-to-Severe Acute Pain
January 04, 2017 07:00 ET | Trevena Inc.
KING OF PRUSSIA, Pa., Jan. 04, 2017 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that it has completed enrollment of its Phase 3 APOLLO-1 and APOLLO-2 pivotal efficacy studies of...
Sucampo Announces New Data on AMITIZA and Opioid-Induced Constipation Published Online in Pain Medicine Journal
May 06, 2014 06:45 ET | Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 6, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, announced that its recent study, "A Randomized Study of...
Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Competitive Technologies, Inc.
June 14, 2010 16:30 ET | Crystal Research Associates, LLC
NEW YORK, NY--(Marketwire - June 14, 2010) -  Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview® (EIO®) on Competitive...